Previous Article | Next Article ![]()
Applied and Environmental Microbiology, March 2000, p. 1152-1157, Vol. 66, No. 3
Pathogènes et Fonctions des Cellules
Epithéliales Polarisées, Institut National de la
Santé et de la Recherche Médicale, Unité 510, Faculté de Pharmacie, Université Paris XI, F-92296
Châtenay-Malabry, France
Received 22 November 1999/Accepted 16 December 1999
To gain further insight into the mechanism by which lactobacilli
develop antimicrobial activity, we have examined how
Lactobacillus acidophilus LB inhibits the promoted cellular
injuries and intracellular lifestyle of Salmonella enterica
serovar Typhimurium SL1344 infecting the cultured, fully differentiated
human intestinal cell line Caco-2/TC-7. We showed that the spent
culture supernatant of strain LB (LB-SCS) decreases the number of
apical serovar Typhimurium-induced F-actin rearrangements in infected
cells. LB-SCS treatment efficiently decreased transcellular passage of
S. enterica serovar Typhimurium. Moreover, LB-SCS treatment
inhibited intracellular growth of serovar Typhimurium, since treated
intracellular bacteria displayed a small, rounded morphology resembling
that of resting bacteria. We also showed that LB-SCS treatment inhibits
adhesion-dependent serovar Typhimurium-induced interleukin-8 production.
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Antagonistic Activity of Lactobacillus
acidophilus LB against Intracellular Salmonella
enterica Serovar Typhimurium Infecting Human Enterocyte-Like
Caco-2/TC-7 Cells
*
Corresponding author. Mailing address: Unité 510, Faculté de Pharmacie, Université Paris XI, F-92296
Châtenay-Malabry, France. Phone: (33) 1.46.83.56.61. Fax: (33)
1.46.83.56.61. E-mail: alain.servin{at}cep.u-psud.fr.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»